Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$0.28 - $1.16 $6,603 - $27,357
23,584 Added 4.15%
591,700 $195,000
Q1 2024

May 10, 2024

BUY
$1.06 - $1.67 $96,637 - $152,248
91,167 Added 19.11%
568,116 $659,000
Q4 2023

Feb 14, 2024

BUY
$1.26 - $1.79 $84,416 - $119,924
66,997 Added 16.34%
476,949 $806,000
Q3 2023

Nov 13, 2023

BUY
$1.61 - $2.54 $205,022 - $323,451
127,343 Added 45.06%
409,952 $742,000
Q2 2023

Jul 31, 2023

BUY
$1.14 - $1.95 $84,402 - $144,372
74,037 Added 35.5%
282,609 $525,000
Q1 2023

May 10, 2023

BUY
$1.2 - $2.19 $29,718 - $54,235
24,765 Added 13.47%
208,572 $277,000
Q4 2022

Feb 07, 2023

BUY
$1.63 - $3.52 $13,765 - $29,726
8,445 Added 4.82%
183,807 $310,000
Q3 2022

Nov 14, 2022

BUY
$0.73 - $3.74 $51,438 - $263,535
70,464 Added 67.17%
175,362 $547,000
Q2 2022

Aug 12, 2022

BUY
$2.2 - $4.2 $230,775 - $440,571
104,898 New
104,898 $250,000
Q1 2022

May 16, 2022

SELL
$2.83 - $8.69 $39,503 - $121,303
-13,959 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$8.31 - $14.92 $35,658 - $64,021
-4,291 Reduced 23.51%
13,959 $116,000
Q3 2021

Nov 15, 2021

BUY
$9.15 - $13.28 $166,987 - $242,360
18,250 New
18,250 $212,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $19B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.